|
Age, ≥40 years
|
3.1 (1.1–8.8)
|
0.034
|
2.6 (0.8–8.9)
|
0.134
|
3.9 (0.9–17.3)
|
0.078
|
6.6 (0.2–180)
|
0.265
|
|
Male sex
|
1.8 (0.6–5.2)
|
0.291
|
1.5 (0.4–5.8)
|
0.555
|
0.7 (0.2–2.9)
|
0.599
|
0.2 (0.1–4.0)
|
0.297
|
|
Place of residence, rural
|
3.7 (1.3–10.7)
|
0.015
|
4.1 (1.2–14.4)
|
0.030
|
5.7 (1.2–28.1)
|
0.032
|
1.5 (0.1–20.7)
|
0.769
|
|
Immunocompromised statea
|
2.9 (0.3–23.8)
|
0.332
| | |
8.0 (0.8–82.5)
|
0.081
|
10.1 (0.4–252)
|
0.159
|
|
Duration of fever at admission, ≥7 days
|
1.2 (0.4–3.5)
|
0.742
| | |
2.5 (0.6–10.9)
|
0.212
| | |
|
Neck stiffness
|
2.8 (1.0–8.1)
|
0.062
| | |
1.9 (0.4–8.0)
|
0.405
| | |
|
Lab findings
|
|
Leukocytosis (≥10×109/L)
|
1.5 (0.5–4.4)
|
0.423
| | |
0.5 (0.1–2.1)
|
0.344
| | |
|
Raised liver enzymes (AST>40 or ALT>35 U/L)
|
1.8 (0.7–5.1)
|
0.244
| | |
0.7 (0.2–2.9)
|
0.618
| | |
|
Raised blood urea (>7.1 mmol/L)
|
2.5 (0.5–11.9)
|
0.258
| | |
5.3 (0.8–33.5)
|
0.076
|
5.5 (0.2–177)
|
0.336
|
|
Raised CRP (≥1 mg/dL)
|
3.8 (1.2–11.7)
|
0.021
| | |
1.8 (0.4–8.2)
|
0.447
| | |
|
CSF analysis
|
|
White blood cells (/μL), ≥100
|
4.1 (1.4–11.9)
|
0.009
| | |
4.6 (0.9–22.3)
|
0.059
| | |
|
Neutrophil count (/μL), ≥50
|
4.1 (1.4–11.9)
|
0.009
| | |
3.1 (0.7–13.7)
|
0.137
| | |
|
Protein (g/L), ≥1.0
|
8.7 (2.6–29.2)
|
<0.001
| | |
20.6 (3.2–133)
|
0.001
| | |
|
CSF/blood glucose ratio, ≤40
|
27.6 (3.5–218.9)
|
0.002
| | |
25.2 (2.5–255)
|
0.006
| | |
|
ADA (IU/L), ≥10
|
26.1 (3.3–206)
|
0.002
|
25.5 (3.1–212)
|
0.003
|
40.5 (3.9–417)
|
0.002
|
42.2 (2.0–882)
|
0.016
|
|
Abnormal CT/MRI
|
0.4 (0.1–1.8)
|
0.256
| | |
0.2 (0.1–1.1)
|
0.070
| | |